Microfluidic Synthesis of PEG- and Folate-Conjugated Liposomes for One-Step Formation of Targeted Stealth Nanocarriers

ABSTRACTPurposeA microfluidic hydrodynamic flow focusing technique enabling the formation of small and nearly monodisperse liposomes is investigated for continuous-flow synthesis of poly(ethylene glycol) (PEG)-modified and PEG-folate-functionalized liposomes for targeted drug delivery.MethodsControlled laminar flow in thermoplastic microfluidic devices facilitated liposome self-assembly from initial lipid compositions including lipid/cholesterol mixtures containing PEG-lipid and folate-PEG-lipid conjugates. Relationships among flow conditions, lipid composition, and liposome size were evaluated; their impact on PEG and folate incorporation were determined through a combination of UV–vis absorbance measurements and characterization of liposome zeta potential.ResultsPEG and folate were successfully incorporated into microfluidic-synthesized liposomes over the full range of liposome sizes studied. Efficiency of PEG-lipid incorporation was inversely correlated with liposome diameter. Folate-lipid was effectively integrated into liposomes at various flow conditions.ConclusionsLiposomes incorporating relatively large PEG-modified and folate-PEG-modified lipids were successfully synthesized using the microfluidic flow focusing platform, providing a simple, low cost, rapid method for preparing functionalized liposomes. Relationships between preparation conditions and PEG or folate-PEG functionalization have been elucidated, providing insight into the process and defining paths for optimization of the microfluidic method toward the formation of functionalized liposomes for pharmaceutical applications.

[1]  Aldo Jesorka,et al.  Liposomes: technologies and analytical applications. , 2008, Annual review of analytical chemistry.

[2]  T. Nakamura,et al.  Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[3]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[4]  P. Low,et al.  Folate Receptor Positive Macrophages: Cellular Targets for Imaging and Therapy of Inflammatory and Autoimmune Diseases , 2011 .

[5]  Justin M. Zook,et al.  Effects of temperature, acyl chain length, and flow-rate ratio on liposome formation and size in a microfluidic hydrodynamic focusing device , 2010 .

[6]  Ponisseril Somasundaran,et al.  ENCYCLOPEDIA OF Surface and Colloid Science , 2006 .

[7]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[8]  T. Allen,et al.  Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time , 1996, FEBS letters.

[9]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[10]  P. Couvreur,et al.  Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.

[11]  Wyatt N Vreeland,et al.  Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. , 2004, Journal of the American Chemical Society.

[12]  K. Edwards,et al.  Cryo transmission electron microscopy of liposomes and related structures , 2000 .

[13]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[14]  Robert J. Lee,et al.  Targeted drug delivery via folate receptors , 2008, Expert opinion on drug delivery.

[15]  Uchiyama,et al.  The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. , 1999, Advanced drug delivery reviews.

[16]  D. Lasič,et al.  Liposomes: From Physics to Applications , 1993 .

[17]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[18]  D. Marsh,et al.  Lipid membrane expansion and micelle formation by polymer-grafted lipids: scaling with polymer length studied by spin-label electron spin resonance. , 2001, Biophysical journal.

[19]  Wyatt N Vreeland,et al.  Microfluidic mixing and the formation of nanoscale lipid vesicles. , 2010, ACS nano.

[20]  J. Nagle,et al.  Structure of lipid bilayers. , 2000, Biochimica et biophysica acta.

[21]  Ratnesh Lal,et al.  Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[22]  Wyatt N Vreeland,et al.  Microfluidic directed formation of liposomes of controlled size. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[23]  P. G. de Gennes,et al.  Conformations of Polymers Attached to an Interface , 1980 .

[24]  A. Baeumner,et al.  Analysis of liposomes. , 2006, Talanta.

[25]  H. K. Mitchell.  Folic Acid. IV. Absorption Spectra , 1944 .

[26]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  H. Harashima,et al.  Liposome Clearance , 2002, Bioscience reports.

[28]  Willis,et al.  Ligand-targeted liposomes. , 1998, Advanced drug delivery reviews.

[29]  Hülya Yılmaz.  Excess Properties of Alcohol - Water Systems at 298.15 K , 2002 .

[30]  C. Sammons.  Liposomal Anthracyclines for Breast Cancer: Overview , 2003 .

[31]  Robert Langer,et al.  Targeted nanoparticles for cancer therapy , 2007 .

[32]  Robert Gurny,et al.  Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.